Contents
Drug Metabolism Letters, Volume 10 - Number 1
A Novel Plated Hepatocyte Relay Assay (PHRA) for In Vitro Evaluation of Hepatic Metabolic Clearance of Slowly Metabolized Compounds
, 10(1): 3 - 15Chi-Chi Peng, Utkarsh Doshi, Chandra Prakash and Albert P. Li
DOI: 10.2174/1872312809666150818111500
A Novel Plated Hepatocyte Relay Assay (PHRA) for In Vitro Evaluation of Hepatic Metabolic Clearance of Slowly Metabolized Compounds
Inactivation of CYP3A4 by Benzbromarone in Human Liver Microsomes
, 10(1): 16 - 21Yasuhiro Masubuchi and Shinji Kondo
DOI: 10.2174/1872312810666151223103208
Inactivation of CYP3A4 by Benzbromarone in Human Liver Microsomes
Metabolism, Excretion and Pharmacokinetics of MLN3897, a CCR1 Antagonist, in Humans
, 10(1): 22 - 37Sandeepraj Pusalkar, Mihaela Plesescu, Mark Milton, Suresh K. Balani, Swapan Chowdhury and Shimoga Prakash
DOI: 10.2174/1872312809666150602152423
Metabolism, Excretion and Pharmacokinetics of MLN3897, a CCR1 Antagonist, in Humans
Clinical Confirmation that the Selective JAK1 Inhibitor Filgotinib (GLPG0634) has a Low Liability for Drug-drug Interactions
, 10(1): 38 - 48Florence Namour, Julie Desrivot, Annegret Van der Aa, Pille Harrison, Chantal Tasset and Gerben van't Klooster
DOI: 10.2174/1872312810666151223103353
Clinical Confirmation that the Selective JAK1 Inhibitor Filgotinib (GLPG0634) has a Low Liability for Drug-drug Interactions
Induction of Haemolysis and DNA Fragmentation in a Normal and Malarial-Infected Blood by Commonly - used Antimalarial Drugs in the North-Western Region of Nigeria
, 10(1): 49 - 55Aliyu Muhammad, Mohammed Auwal Ibrahim, Ochuko Lucky Erukainure, Nathan Habila, Aimola Asegame Idowu, Uche Samuel Ndidi, Ibrahim Malami, Halliru Zailani, Zeenat Bello Kudan and Bilal Abdullahi Muhammad
DOI: 10.2174/187231281001160212150630
Induction of Haemolysis and DNA Fragmentation in a Normal and Malarial-Infected Blood by Commonly - used Antimalarial Drugs in the North-Western Region of Nigeria
Common and Distinct Interactions of Chemical Inhibitors with Cytochrome P450 CYP1A2, CYP2A6 and CYP2B6 Enzymes
, 10(1): 56 - 64Hannu Raunio, Risto O. Juvonen, Antti Poso, Maija Lahtela-Kakkonen and Minna Rahnasto-Rilla
DOI: 10.2174/1872312810666151204002456
Common and Distinct Interactions of Chemical Inhibitors with Cytochrome P450 CYP1A2, CYP2A6 and CYP2B6 Enzymes
Impact of Cytochrome P450 2C19*2 and *3 on Clopidogrel Loading Dose in Saudi Patients with Acute Coronary Syndrome
, 10(1): 65 - 70Hassan Khalaf, Ahmad AbdulRahman Al Meman and Seemab Rasool
DOI: 10.2174/1872312810666151117122841
Impact of Cytochrome P450 2C19*2 and *3 on Clopidogrel Loading Dose in Saudi Patients with Acute Coronary Syndrome
Webmaster Contact: info@benthamscience.net